Some patients who recovered from Covid-19 have suffered reduced lung function and now experience problems such as gasping for air when walking quickly. Researchers said the long-term effect on recovered patients, such as whether they would develop pulmonary fibrosis, a condition where lung tissue hardened and the organ could not function properly, had yet to be ascertained. Computer tomography have shown fluid or debris-filled sacs in the lungs, which may get progressively worse as the illness develops.
Covid-19 patients are being treated with Kaletra, a drug originally for HIV/Aids; Ribavirin, which was also used for hepatitis C; and interferon. Chinese researchers have found fluid or debris-filled sacs in the lungs of those who were infected by COVID-19. Scans suggest sustained organ damage. More than 86,000 people worldwide have now recovered from the lung disease COVID-19. In their case, the infection manifested itself in mild or moderate form, or it’s because these patients received excellent medical care.
This number can provide solace, on the one hand, but on the other there is still little information about how these people are doing after the infection has run its course.
With great relief and joy, some convalescents describe how they have survived the physical, but above all psychological stress: the healing of symptoms, the agonizing uncertainty, and the gruelling isolation phase. They are happy to be immune to SARS-CoV-2 after having survived the illness. Relief is often mixed with apprehension – for instance, with regard to the many people who have not yet infected.
Further investigations of the recovered COVID-19 patients must now be conducted to show whether they have developed pulmonary fibrosis. Pulmonary fibrosis (PF) means scarring in the lungs. Over time, the scar tissue can destroy the normal lung and make it hard for oxygen to get into your blood. Low oxygen levels (and the stiff scar tissue itself) can cause short of breath, particularly, during physical exertion. Lung fibrosis cannot be cured because the scarred changes in the lung tissue do not regress. But the progression of pulmonary fibrosis can be delayed and sometimes even stopped if detected in time.
On March 2, a man in Wuhan, China, with COVID-19 died after being readmitted to the hospital two days after he was discharged, according to a Chinese news site.